Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (21 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Product sales
2
3
6
8
6
6
Licensing revenue
0
0
0
1
0
0
Total revenue
2
3
6
9
0
0
Cost of product sales
1
1
3
5
3
3
Gross Profit
1
1
2
4
3
4
Research and development
0
1
0
0
1
1
Sales and Marketing
0
0
1
1
1
3
General and administrative
2
2
2
3
4
5
Total operating expenses
2
3
3
4
6
9
Operating loss
-1
-1
-1
0
-3
-5
Interest income
0
0
0
0
0
0
Interest expense, related party
-1
-1
-1
-1
0
0
Amortization of deferred financing costs
0
0
0
0
0
0
Loss on disposal of property and equipment
0
0
0
0
0
0
Gain on disposal of property and equipment
0
0
0
0
0
0
Total other income (expenses)
-1
-1
-1
-1
0
0
Net loss
0
0
0
-1
-3
-5
Net loss attributable to non-controlling interest
0
0
0
0
0
1
Net Loss attributable to BioLife Solutions, Inc.
-2
-2
-2
-1
-3
-4
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 29, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (39 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
0
0
0
0
3
2
Short term investments
0
0
0
0
7
2
Accounts receivable, trade, net of allowances
0
1
1
1
1
1
Inventories
0
1
1
0
1
2
Prepaid expenses and other current assets
0
0
0
0
0
0
Total current assets
1
1
2
2
12
7
Leasehold improvements
0
0
1
1
1
1
Furniture and computer equipment
0
0
0
0
0
1
Manufacturing and other equipment
1
1
1
1
1
1
Subtotal
1
1
2
2
3
3
Less: accumulated depreciation
0
0
-1
-1
-1
-1
Net property and equipment
0
0
1
1
2
1
Internal use software
0
0
0
0
0
2
Intangible asset
0
0
0
0
2
2
Long term deposits
0
0
0
0
0
0
Deferred financing costs, net
0
0
0
0
0
0
Total assets
1
2
3
3
16
12
Liabilities and owners' equity
Accounts payable
0 117068
0 403103
1 862492
1 867070
0 474662
1 1029373
Note payable, related party, net of discount
0 0
0 0
0 0
0 0
0 0
0 0
Accrued interest, related party
0 0
2 2025961
0 0
0 0
0 0
0 0
Accrued expenses and other current liabilities
0 108015
0 69582
0 8495
0 146626
0 121869
0 146438
Accrued compensation
0 95619
0 86563
0 363101
1 503194
1 535029
0 419766
Deferred rent
0 0
0 0
0 111250
0 111250
0 130216
0 130216
Deferred revenue
0 20000
0 20000
0 20000
0 0
0 0
0 0
Total current liabilities
0 340702
1 579248
1 1365338
2 1628140
1 1261776
2 1725793
Deferred rent, long term
0 0
0 0
1 838829
1 891986
1 874825
1 784458
Promissory notes payable, related parties
9 9033127
10 10128127
11 10603127
11 10603127
0 0
0 0
Accrued interest, related parties
1 1354975
0 0
3 2759391
4 3501610
0 0
0 0
Deferred revenue, long term
0 129167
0 109167
0 89167
0 0
0 0
0 0
Total liabilities
11 10857971
13 12842503
16 15655852
17 16624863
2 2136601
3 2510251
Commitments and contingencies (Note 9)
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
0 69680
0 69680
0 4977
0 5030
0 12084
0 12447
Additional paid-in capital
43 42576260
43 42901325
43 43320077
44 43618686
72 71911328
73 72823398
Accumulated other comprehensive loss
0 0
0 0
0 0
0 0
0 -6448
0 -451
Accumulated deficit
-52 -52194852
-54 -54151491
-56 -55811077
-57 -56895237
-60 -60112987
-64 -64326923
Total BioLife Solutions, Inc. shareholders' equity
0 0
0 0
0 0
-13 -13271521
12 11803977
10 9859371
Total non-controlling interest equity
0 0
0 0
0 0
0 0
2 2132340
1 1350900
Total shareholders' equity
-10 -9548912
-11 -11180486
-12 -12486023
-13 -13271521
14 13936317
9 8508471
Total liabilities and shareholders' equity
1 1309059
2 1662017
3 3169829
3 3353342
16 16072918
12 12369622
Remarks restated on Nov 30, -1 n/a restated on Mar 29, 2013 n/a restated on Feb 12, 2014 n/a restated on Mar 12, 2015 n/a restated on Feb 25, 2016 n/a restated on Nov 10, 2016 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (32 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net loss
-2
-2
-2
-1
-3
-5
Depreciation
0
0
0
0
0
0
Gain on disposal of property and equipment
0
0
0
0
0
0
Stock-based compensation
0
0
0
0
0
1
Stock issued for services
0
0
0
0
0
0
Write-off of deferred financing costs
0
0
0
0
0
0
Lease incentive received from landlord, net of amortization
0
0
0
0
0
0
Lease incentives received from landlord, net of amortization of deferred rent related to lease incentives
0
0
1
0
0
0
Accretion and amortization on available for sale investments
0
0
0
0
0
0
(Increase) Decrease in Accounts receivable, trade
0
0
0
0
0
0
Inventories
0
0
0
0
-1
-1
Prepaid expenses and other current assets
0
0
0
0
0
0
Accounts payable
0
0
0
0
0
0
Accrued compensation and other current liabilities
0
0
0
0
0
0
Deferred rent
0
0
0
0
0
0
Net cash used in operating activities
-1
-1
1
0
-3
-5
Accrued interest, related parties
1
1
1
1
0
0
Deferred revenue
0
0
0
0
0
0
Purchase of available-for-sale investments
0
0
0
0
-8
-1
Sales of available-for-sale investments
0
0
0
0
0
7
Cash received from sale of property and equipment
0
0
0
0
0
0
Costs associated with internal use software development
0
0
0
0
0
-1
Purchase of property and equipment
0
0
-1
0
-1
0
Net provided by investing activities
0
0
-1
0
-8
4
Proceeds from Related Party Debt
1
1
0
0
0
0
Proceeds from exercise of common stock options
0
0
0
0
0
0
Net cash provided by financing activities
1
1
0
0
14
0
Proceeds from sale of common stock, net of expenses
0
0
0
0
14
0
Net increase (decrease) in cash and cash equivalents
0
0
0
0
2
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 29, 2013 n/a
calculated values,
restated on Feb 12, 2014 n/a
calculated values,
restated on Mar 12, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,